A possible homology between immunodeficiency virus p24 core protein and picornaviral VP2 coat protein: prediction of HIV p24 antigenic sites
- PMID: 2498082
- PMCID: PMC400874
- DOI: 10.1002/j.1460-2075.1989.tb03438.x
A possible homology between immunodeficiency virus p24 core protein and picornaviral VP2 coat protein: prediction of HIV p24 antigenic sites
Abstract
With the use of a sensitive sequence comparison algorithm, a homology has been suggested between the primary structures of simian immunodeficiency virus (SIV) p24 core protein and foot-and-mouth disease virus (FMD) VP2 coat protein. Since the FMD sequence is homologous to picornaviral VP2 sequences with known three-dimensional architecture and since the SIV p24 sequence can be convincingly aligned with that from human immunodeficiency virus (HIV), it was possible to predict an eight-stranded beta-barrel fold for the HIV core protein. From analogy with the known environments of the picornaviral coats, p24 sequence spans could be predicted as likely candidates for antibody attachment. These suggestions may be important for development of an AIDS vaccine.
Similar articles
-
Conserved immunogenic region of a major core protein (p24) of human and simian immunodeficiency viruses.AIDS Res Hum Retroviruses. 1988 Dec;4(6):409-17. doi: 10.1089/aid.1988.4.409. AIDS Res Hum Retroviruses. 1988. PMID: 2464360
-
Monoclonal antibodies against human immunodeficiency virus (HIV) type 2 core proteins: cross-reactivity with HIV type 1 and simian immunodeficiency virus.Proc Natl Acad Sci U S A. 1988 Sep;85(18):6939-43. doi: 10.1073/pnas.85.18.6939. Proc Natl Acad Sci U S A. 1988. PMID: 2457921 Free PMC article.
-
Use of TrpE/Gag fusion proteins to characterize immunoreactive domains on the human immunodeficiency virus type 1 core protein.J Virol. 1989 Sep;63(9):4064-8. doi: 10.1128/JVI.63.9.4064-4068.1989. J Virol. 1989. PMID: 2474676 Free PMC article.
-
SIV neutralization epitopes.Chem Immunol. 1993;56:78-90. Chem Immunol. 1993. PMID: 7680868 Review. No abstract available.
-
Antigenic and immunogenic sites of HIV-2 glycoproteins.Chem Immunol. 1993;56:61-77. doi: 10.1159/000319156. Chem Immunol. 1993. PMID: 8452654 Review.
Cited by
-
Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles.J Virol. 1995 Apr;69(4):2366-77. doi: 10.1128/JVI.69.4.2366-2377.1995. J Virol. 1995. PMID: 7884882 Free PMC article.
-
Preparation and crystallization of a human immunodeficiency virus p24-Fab complex.Proc Natl Acad Sci U S A. 1990 Dec;87(24):9980-4. doi: 10.1073/pnas.87.24.9980. Proc Natl Acad Sci U S A. 1990. PMID: 2124709 Free PMC article.
-
Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.J Virol. 1994 Jan;68(1):111-22. doi: 10.1128/JVI.68.1.111-122.1994. J Virol. 1994. PMID: 8254720 Free PMC article.
-
Molecular mimicry and autoantigens in connective tissue diseases.Mol Biol Rep. 1992 Jun;16(3):139-47. doi: 10.1007/BF00464701. Mol Biol Rep. 1992. PMID: 1380637 Review. No abstract available.
-
Assembly-defective point mutants of the human immunodeficiency virus type 1 Gag precursor phenotypically expressed in recombinant baculovirus-infected cells.J Virol. 1993 May;67(5):2787-98. doi: 10.1128/JVI.67.5.2787-2798.1993. J Virol. 1993. PMID: 8474175 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources